CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

CHAPTER 2: EXECUTIVE SUMMARY

2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Market share analysis, 2017
3.4. Porters five forces analysis
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Increase in incidence of thyroid gland disorders
3.5.1.2. Development of effective combination thyroid disorders drug therapies
3.5.1.3. Increase in number of disease awareness programs in developing regions

3.5.2. Restraints

3.5.2.1. Side effects that cause lesser patient adherence
3.5.2.2. Stringent government regulations

3.5.3. Opportunities

3.5.3.1. Availability of large pool of undiagnosed patients due to asymptomatic nature of thyroid disorders

CHAPTER 4: THYROID GLAND DISORDER TREATMENT MARKET, BY DISEASE TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Hypothyroidism

4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Hyperthyroidism

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

CHAPTER 5: THYROID GLAND DISORDER TREATMENT MARKET, BY DRUG TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Levothyroxine

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Liothyronine

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Propylthiouracil

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

5.5. Imidazole-based compounds

5.5.1. Market size and forecast
5.5.2. Market analysis, by country

5.6. Others

5.6.1. Market size and forecast
5.6.2. Market analysis, by country

CHAPTER 6: THYROID GLAND DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Oral route

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. Intravenous route

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.4. Others

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

CHAPTER 7: THYROID GLAND DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL

7.1. Overview

7.1.1. Market size and forecast

7.2. Wholesalers/Distributors

7.2.1. Market size and forecast
7.2.2. Market analysis, by country

7.3. Retailer

7.3.1. Market size and forecast
7.3.2. Market analysis, by country

7.4. Mail-Order Pharmacy

7.4.1. Market size and forecast
7.4.2. Market analysis, by country

7.5. Others

7.5.1. Market size and forecast
7.5.2. Market analysis, by country

CHAPTER 8: THYROID GLAND DISORDER TREATMENT MARKET, BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends and opportunities
8.2.2. North America thyroid gland disorder treatment market by disease type
8.2.3. North America thyroid gland disorder treatment market by drug type
8.2.4. North America thyroid gland disorder treatment market by route of administration
8.2.5. North America thyroid gland disorder treatment market by distribution channel
8.2.6. Market size and forecast, by country

8.2.6.1. U.S. thyroid gland disorder treatment market by disease type
8.2.6.2. U.S. thyroid gland disorder treatment market by drug type
8.2.6.3. U.S. thyroid gland disorder treatment market by route of administration
8.2.6.4. U.S. thyroid gland disorder treatment market by distribution channel
8.2.6.5. Canada thyroid gland disorder treatment market by disease type
8.2.6.6. Canada thyroid gland disorder treatment market by drug type
8.2.6.7. Canada thyroid gland disorder treatment market by route of administration
8.2.6.8. Canada thyroid gland disorder treatment market by distribution channel
8.2.6.9. Mexico thyroid gland disorder treatment market by disease type
8.2.6.10. Mexico thyroid gland disorder treatment market by drug type
8.2.6.11. Mexico thyroid gland disorder treatment market by route of administration
8.2.6.12. Mexico thyroid gland disorder treatment market by distribution channel

8.3. EUROPE

8.3.1. Key market trends and opportunities
8.3.2. Europe thyroid gland disorder treatment market by disease type
8.3.3. Europe thyroid gland disorder treatment market by drug type
8.3.4. Europe thyroid gland disorder treatment market by route of administration
8.3.5. Europe thyroid gland disorder treatment market by distribution channel
8.3.6. Market size and forecast, by country

8.3.6.1. Germany thyroid gland disorder treatment market by disease type
8.3.6.2. Germany thyroid gland disorder treatment market by drug type
8.3.6.3. Germany thyroid gland disorder treatment market by route of administration
8.3.6.4. Germany thyroid gland disorder treatment market by distribution channel
8.3.6.5. France thyroid gland disorder treatment market by disease type
8.3.6.6. France thyroid gland disorder treatment market by drug type
8.3.6.7. France thyroid gland disorder treatment market by route of administration
8.3.6.8. France thyroid gland disorder treatment market by distribution channel
8.3.6.9. UK thyroid gland disorder treatment market by disease type
8.3.6.10. UK thyroid gland disorder treatment market by drug type
8.3.6.11. UK thyroid gland disorder treatment market by route of administration
8.3.6.12. UK thyroid gland disorder treatment market by distribution channel
8.3.6.13. Italy thyroid gland disorder treatment market by disease type
8.3.6.14. Italy thyroid gland disorder treatment market by drug type
8.3.6.15. Italy thyroid gland disorder treatment market by route of administration
8.3.6.16. Italy thyroid gland disorder treatment market by distribution channel
8.3.6.17. Spain thyroid gland disorder treatment market by disease type
8.3.6.18. Spain thyroid gland disorder treatment market by drug type
8.3.6.19. Spain thyroid gland disorder treatment market by route of administration
8.3.6.20. Spain thyroid gland disorder treatment market by distribution channel
8.3.6.21. Rest of Europe thyroid gland disorder treatment market by disease type
8.3.6.22. Rest of Europe thyroid gland disorder treatment market by drug type
8.3.6.23. Rest of Europe thyroid gland disorder treatment market by route of administration
8.3.6.24. Rest of Europe thyroid gland disorder treatment market by distribution channel

8.4. Asia-Pacific

8.4.1. Key trends and opportunities
8.4.2. Asia-Pacific thyroid gland disorder treatment market by disease type
8.4.3. Asia-Pacific thyroid gland disorder treatment market by drug type
8.4.4. Asia-Pacific thyroid gland disorder treatment market by route of administration
8.4.5. Asia-Pacific thyroid gland disorder treatment market by distribution channel
8.4.6. Market size and forecast, by country

8.4.6.1. Japan thyroid gland disorder treatment market by disease type
8.4.6.2. Japan thyroid gland disorder treatment market by drug type
8.4.6.3. Japan thyroid gland disorder treatment market by route of administration
8.4.6.4. Japan thyroid gland disorder treatment market by distribution channel
8.4.6.5. China thyroid gland disorder treatment market by disease type
8.4.6.6. China thyroid gland disorder treatment market by drug type
8.4.6.7. China thyroid gland disorder treatment market by route of administration
8.4.6.8. China thyroid gland disorder treatment market by distribution channel
8.4.6.9. Australia thyroid gland disorder treatment market by disease type
8.4.6.10. Australia thyroid gland disorder treatment market by drug type
8.4.6.11. Australia thyroid gland disorder treatment market by route of administration
8.4.6.12. Australia thyroid gland disorder treatment market by distribution channel
8.4.6.13. India thyroid gland disorder treatment market by disease type
8.4.6.14. India thyroid gland disorder treatment market by drug type
8.4.6.15. India thyroid gland disorder treatment market by route of administration
8.4.6.16. India thyroid gland disorder treatment market by distribution channel
8.4.6.17. South Korea thyroid gland disorder treatment market by disease type
8.4.6.18. South Korea thyroid gland disorder treatment market by drug type
8.4.6.19. South Korea thyroid gland disorder treatment market by route of administration
8.4.6.20. South Korea thyroid gland disorder treatment market by distribution channel
8.4.6.21. Rest of Asia-Pacific thyroid gland disorder treatment market by disease type
8.4.6.22. Rest of Asia-Pacific thyroid gland disorder treatment market by drug type
8.4.6.23. Rest of Asia-Pacific thyroid gland disorder treatment market by route of administration
8.4.6.24. Rest of Asia-Pacific thyroid gland disorder treatment market by distribution channel

8.5. LAMEA

8.5.1. Key market trends and opportunities
8.5.2. LAMEA thyroid gland disorder treatment market by disease type
8.5.3. LAMEA thyroid gland disorder treatment market by drug type
8.5.4. LAMEA thyroid gland disorder treatment market by route of administration
8.5.5. LAMEA thyroid gland disorder treatment market by distribution channel
8.5.6. Market size and forecast, by country

8.5.6.1. Brazil thyroid gland disorder treatment market by disease type
8.5.6.2. Brazil thyroid gland disorder treatment market by drug type
8.5.6.3. Brazil thyroid gland disorder treatment market by route of administration
8.5.6.4. Brazil thyroid gland disorder treatment market by distribution channel
8.5.6.5. Saudi Arabia thyroid gland disorder treatment market by disease type
8.5.6.6. Saudi Arabia thyroid gland disorder treatment market by drug type
8.5.6.7. Saudi Arabia thyroid gland disorder treatment market by route of administration
8.5.6.8. Saudi Arabia thyroid gland disorder treatment market by distribution channel
8.5.6.9. South Africa thyroid gland disorder treatment market by disease type
8.5.6.10. South Africa thyroid gland disorder treatment market by drug type
8.5.6.11. South Africa thyroid gland disorder treatment market by route of administration
8.5.6.12. South Africa thyroid gland disorder treatment market by distribution channel
8.5.6.13. Rest of LAMEA thyroid gland disorder treatment market by disease type
8.5.6.14. Rest of LAMEA thyroid gland disorder treatment market by drug type
8.5.6.15. Rest of LAMEA thyroid gland disorder treatment market by route of administration
8.5.6.16. Rest of LAMEA thyroid gland disorder treatment market by distribution channel

CHAPTER 9: COMPANY PROFILES

9.1. Abbott Laboratories

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance

9.2. AbbVie Inc.

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segment
9.2.4. Product portfolio
9.2.5. Business performance

9.3. Allergan Plc.

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance

9.4. GlaxoSmithKline plc

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance

9.5. Lannett Company, Inc.

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance

9.6. Merck & Co. Inc.

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance

9.7. Mylan N.V.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance

9.8. Novartis AG

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance

9.9. Pfizer Inc.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance

9.10. RLC LABS, Inc.

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio